Cite
HARVARD Citation
Martin-Loeches, I. et al. (2022). Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia. Journal of antimicrobial chemotherapy. pp. 1166-1177. [Online].